Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity

Infection and Immunity

Volumn 78, Issue 9, 2010, Pages 3969-3980

  Wang, Shifeng ^a,b   Li, Yuhua ^a   Scarpellini, Giorgio ^a,b   Kong, Wei ^a,b   Shi, HuoYing ^a   Baek, Chang Ho ^a,b   Gunn, Bronwyn ^a,b   Wanda, Soo Young ^a,b   Roland, Kenneth L ^a   Zhang, Xin ^b   Senechal Willis, Patti ^a   Curtiss III, Roy ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; BACTERIAL PROTEIN; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN PSPA; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; LAC REPRESSOR; LIVE VACCINE; PNEUMOCOCCAL SURFACE PROTEIN A; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL DIVISION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; LACI GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REGULATED DELAYED ANTIGEN SYNTHESIS; REPRESSOR GENE; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; FEMALE; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; PATHOGENICITY; PLASMID; PROMOTER REGION; SALMONELLA; VIRULENCE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LAC REPRESSORS; MICE; MICE, INBRED BALB C; PLASMIDS; PROMOTER REGIONS, GENETIC; SALMONELLA; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRULENCE;

EID: 77956625002     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00444-10     Document Type: Article

References (74)

1. Amann, E., B. Ochs, and K. J. Abel. 1988. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 69:301-315.
2. Anderson, R., G. Dougan, and M. Roberts. 1996. Delivery of the Pertactin/ P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response. Vaccine 14:1384-1390.
3. Baek, C. H., S. Wang, K. L. Roland, and R. Curtiss III. 2009. Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J. Bacteriol. 191:1278-1292.
4. Bass, R., L. Heffernan, K. Sweadner, and E. Englesberg. 1976. The site for catabolite deactivation in the L-arabinose BAD operon in Escherichia coli B/r. Arch. Microbiol. 110:135-143.
5. Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
6. Betz, J. L., and M. Z. Fall. 1988. Effects of dominant-negative lac repressor mutations on operator specificity and protein stability. Gene 67:147-158.
7. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
8. Brosius, J., M. Erfle, and J. Storella. 1985. Spacing of the -10 and -35 regions in the tac promoter. Effect on its in vivo activity. J. Biol. Chem. 260:3539-3541.
9. +-T-cell responses. Infect. Immun. 69:7493-7500.
10. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology (N Y). 10:888-892.
11. Curtiss, R., III, S. Y. Wanda, B. M. Gunn, X. Zhang, S. A. Tinge, V. Ananthnarayan, H. Mo, S. Wang, and W. Kong. 2009. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect. Immun. 77:1071-1082.
12. Curtiss, R., III., and H. Y. Kang. 2004. Immunogenic compositions and vaccines comprising carrier bacteria that secrete antigens. US patent 2004/0101531.
13. Curtiss, R., III., and W. Kong. 2006. Regulated bacterial lysis for gene vaccine vector delivery and antigen release. US patent 20060140975.
14. Curtiss, R., III., S. B. Porter, M. Munson, S. A. Tinge, J. O. Hassan, C. Gentry-Weeks, and S. M. Kelly. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p. 169-198. In L. C. Blankenship, J. H. S. Bailey, N. A. Cox, N. J. Stern, and R. J. Meinersmann (ed.), Colonization control of human bacterial enteropathogens in poultry. Academic Press New York.
15. Daber, R., and M. Lewis. 2009. Towards evolving a better repressor. Protein Eng. Des Sel. 22:673-683.
16. Daniels, C. C., P. Coan, J. King, J. Hale, K. A. Benton, D. E. Briles, and S. K. Hollingshead. 2010. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis. Infect. Immun. 78:2163-2172.
17. + T cell clones. Semin. Immunol. 5:421-430.
18. Dusek, D. M., A. Progulske-Fox, and T. A. Brown. 1994. Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin. Infect. Immun. 62:1652-1657.
19. Edwards, R. A., L. H. Keller, and D. M. Schifferli. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.
20. Eswarappa, S. M., G. Karnam, A. G. Nagarajan, S. Chakraborty, and D. Chakravortty. 2009. lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella. PLoS One 4:e5789.
21. Fooks, A. R. 2000. Development of oral vaccines for human use. Curr. Opin. Mol. Ther. 2:80-86.
22. Fraser, D., and E. A. Jerrel. 1953. The amino acid composition of T3 bacteriophage. J. Biol. Chem. 205:291-295.
23. Galen, J. E., and M. M. Levine. 2001. Can. a 'flawless' live vector vaccine strain be engineered? Trends Microbiol. 9:372-376.
24. Gay, P., D. Le Coq, M. Steinmetz, T. Berkelman, and C. I. Kado. 1985. Positive selection procedure for entrapment of insertion sequence elements in gram-negative bacteria. J. Bacteriol. 164:918-921.
25. Gentschev, I., G. Dietrich, and W. Goebel. 2002. The E. coli α-hemolysin secretion system and its use in vaccine development. Trends Microbiol. 10:39-45.
26. Gilbert, W. 1972. The lac repressor and the lac operator. Ciba Found. Symp. 7:245-259.
27. Gilbert, W., and B. Müller-Hill. 1966. Isolation of the Lac Repressor. Proc. Natl. Acad. Sci. U. S. A. 56:1891-1898.
28. Gor, D. O., N. R. Rose, and N. S. Greenspan. 2003. TH1-TH2: a procrustean paradigm. Nat. Immunol. 4:503-505.
29. BAD promoter. J. Bacteriol. 177:4121-4130.
30. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
31. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. U. S. A. 92:2904-2908.
32. Hopkins, S., J. P. Kraehenbuhl, F. Schödel, A. Potts, D. Peterson, P. de Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
33. Isoda, R., S. P. Simanski, L. Pathangey, A. E. Stone, and T. A. Brown. 2007. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector. Vaccine 25:117-126.
34. Kang, H. Y., and R. Curtiss III. 2003. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 37:99-104.
35. Kang, H. Y., C. M. Dozois, S. A. Tinge, T. H. Lee, and R. Curtiss III. 2002. Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J. Bacteriol. 184:307-312.
36. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
37. Katzman, R. L., E. Lisowska, and R. W. Jeanloz. 1970. Invertebrate connective tissue. Isolation of D-arabinose from sponge acidic polysaccharide. Biochem. J. 119:17-19.
38. Kolodrubetz, D., and R. Schleif. 1981. Regulation of the L-arabinose transport operons in Escherichia coli. J. Mol. Biol. 151:215-227.
39. Kong, W., S. Y. Wanda, X. Zhang, W. Bollen, S. A. Tinge, K. L. Roland, and R. Curtiss III. 2008. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc. Natl. Acad. Sci. U. S. A. 105:9361-9366.
40. Lee, J. H., R. J. Russo, L. Heffernan, and G. Wilcox. 1982. Regulation of L-arabinose transport in Salmonella typhimurium LT2. Mol. Gen. Genet. 185:136-141.
41. Lee, J. S., K. S. Shin, J. G. Pan, and C. J. Kim. 2000. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat. Biotechnol. 18:645-648.
42. Lewis, M. 2005. The lac repressor. C R Biol. 328:521-548.
43. Li, Y., S. Wang, G. Scarpellini, B. Gunn, W. Xin, S. Y. Wanda, K. L. Roland, and R. Curtiss III. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 106:593-598.
44. Marshall, D. G., A. Haque, R. Fowler, G. Del Guidice, C. J. Dorman, G. Dougan, and F. Bowe. 2000. Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains. Vaccine. 18:1298-1306.
45. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
46. Mossing, M. C., and M. T. Record, Jr. 1986. Upstream operators enhance repression of the lac promoter. Science 233:889-892.
47. Müller-Hill, B. 1975. Lac repressor and lac operator. Prog. Biophys. Mol. Biol. 30:227-252.
48. Müller-Hill, B., L. Crapo, and W. Gilbert. 1968. Mutants that make more lac repressor. Proc. Natl. Acad. Sci. U. S. A. 59:1259-1264.
49. Müller, J., S. Oehler, and B. Müller-Hill. 1996. Repression of lac promoter as a function of distance, phase and quality of an auxiliary lac operator. J. Mol. Biol. 257:21-29.
50. Nakayama, K., S. M. Kelly, and R. Curtiss III. 1988. Construction of an ASD expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Biotechnology 6:693-697.
51. Nayak, A. R., S. A. Tinge, R. C. Tart, L. S. McDaniel, D. E. Briles, and R. Curtiss III. 1998. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 66:3744-3751.
52. Neutra, M. R., E. Pringault, and J. P. Kraehenbuhl. 1996. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. 14:275-300.
53. O'Callaghan, D., and A. Charbit. 1990. High efficiency transformation of Salmonella typhimurium and Salmonella typhi by electroporation. Mol. Gen. Genet. 223:156-158.
54. Oehler, S., E. R. Eismann, H. Kramer, and B. Muller-Hill. 1990. The three operators of the lac operon cooperate in repression. EMBO J. 9:973-979.
55. Pascual, D. W., D. M. Hone, S. Hall, F. W. van Ginkel, M. Yamamoto, N. Walters, K. Fujihashi, R. J. Powell, S. Wu, J. L. Vancott, H. Kiyono, and J. R. McGhee. 1999. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 67:6249-6256.
56. Pashine, A., B. John, S. Rath, A. George, and V. Bal. 1999. Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int. Immunol. 11:481-489.
57. Pizarro-Cerda, J., and K. Tedin. 2004. The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression. Mol. Microbiol. 52:1827-1844.
58. Platt, T., J. H. Miller, and K. Weber. 1970. In vivo degradation of mutant lac repressor. Nature 228:1154-1156.
59. Pueyo, C., and J. Lopez-Barea. 1979. The L-arabinose-resistance test with Salmonella typhimurium strain SV3 selects forward mutations at several ara genes. Mutat. Res. 64:249-258. (Pubitemid 9232890)
60. Ramarathinam, L., D. W. Niesel, and G. R. Klimpel. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J. Immunol. 150:3973-3981.
61. Roland, K., R. Curtiss III. and D. Sizemore. 1999. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 43:429-441.
62. Sadler, J. R., H. Sasmor, and J. L. Betz. 1983. A perfectly symmetric lac operator binds the lac repressor very tightly. Proc. Natl. Acad. Sci. U. S. A. 80:6785-6789.
63. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
64. Schmieger, H., and H. Backhaus. 1976. Altered cotransduction frequencies exhibited by HT-mutants of Salmonella-phage P22. Mol. Gen. Genet. 143: 307-309.
65. Schödel, F., S. M. Kelly, D. L. Peterson, D. R. Milich, and R. Curtiss III. 1994. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62:1669-1676.
66. Shalaby, W. S. 1995. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin. Immunol. Immunopathol. 74:127-134.
67. Shi, H., S. Wang, K. L. Roland, B. M. Gunn, and R. Curtiss III. 2010. Immunogenicity of a Live Recombinant Salmonella enterica serovar Typhimurium vaccine expressing pspA in neonates and infant mice born from naïve and immunized mothers. Clin. Vaccine Immunol. 17:363-371.
68. Siegele, D. A., and J. C. Hu. 1997. Gene expression from plasmids containing the araBAD promoter at subsaturating inducer concentrations represents mixed populations. Proc. Natl. Acad. Sci. U. S. A. 94:8168-8172.
69. Sternberg, N. L., and R. Maurer. 1991. Bacteriophage-mediated generalized transduction in Escherichia coli and Salmonella typhimurium. Methods Enzymol. 204:18-43.
70. Wang, S., Y. Li, H. Shi, G. Scarpellini, A. Torres-Escobar, K. L. Roland, and R. Curtiss III. 2010. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect. Immun. 78:3258-3271.
71. Xin, W., S. Y. Wanda, Y. Li, S. Wang, H. Mo, and R. Curtiss III. 2008. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect. Immun. 76:3241-3254.
72. Zahn, K. 1996. Overexpression of an mRNA dependent on rare codons inhibits protein synthesis and cell growth. J. Bacteriol. 178:2926-2933.
73. Zekarias, B., H. Mo, and R. Curtiss III. 2008. Recombinant attenuated Salmonella enterica serovar Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin. Vaccine Immunol. 15:805-816.
74. Zinkernagel, R. M., S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localisation regulates immune responses in a doseand time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:199-209.